Sunshine Biopharma Inc. - SBFM

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$139K
QoQ value delta ($000)
-$194K (-58.26%)
Implied price effect (QoQ)
-17.82%
Shares
Total shares
114,999
QoQ shares delta
-111,400 (-49.21%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SBFM)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 12 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 66 53,929 0.0%
Virtu Financial LLC 29 23,388 0.0%
XTX Topco Ltd 19 16,156 0.0%
MORGAN STANLEY 18 14,634 0.0%
SBI Securities Co., Ltd. 5 4,848 0.0%
UBS Group AG 2 1,873 0.0%
BANK OF AMERICA CORP /DE/ 0 5 0.0%
NATIONAL BANK OF CANADA /FI/ 0 10 0.0%
OSAIC HOLDINGS, INC. 0 152 0.0%
SageView Advisory Group, LLC 0 1 0.0%
Farther Finance Advisors, LLC 0 1 0.0%
TD Waterhouse Canada Inc. 0 1 0.0%
Strive Financial Group ,LLC 0 1 0.0%